Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-Mercaptocysteine is an organic compound classified as an L-cysteine-S-conjugate and is also known as thiocysteine or cysteine persulfide. Its chemical formula is C3H7NO2S2 and it has a molecular weight of approximately 153.23 g/mol[1][2]. S-Mercaptocysteine is a sulfur-containing amino acid derivative where the sulfur atom in the side chain of cysteine forms a persulfide (–SSH) group instead of the typical thiol (–SH). It occurs naturally as a human and mouse metabolite[2]. The biological role of S-mercaptocysteine includes participation in sulfur metabolism; it may act as an intermediate or product in enzymatic reactions involving sulfur transfer. Its mechanism of action at the pharmacological level remains largely uncharacterized, but related compounds are involved in redox biology and cellular signaling through hydrogen sulfide (H2S) production[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-Mercaptocysteine.